CLYM Stock Analysis: Buy, Sell, or Hold?
CLYM - Climb Bio, Inc. Common Stock
$6.85
0.31 (4.74%)
▲
5d:
+2.54%
30d:
-3.11%
90d:
+54.28%
BUY
HIGH Confidence
Analysis Updated: Mar 31, 2026 12:00 AM ET
Earnings: May 13, 2026
Get Alerted When CLYM Hits Your Target Price
Join 10,000+ traders who never miss a move
You're in! Check your email to confirm and set your target price.
100% Free
No spam, ever
Unsubscribe anytime
Interactive Price Chart (1 Month)
Loading chart...
Loading historical data...
Bottom Line:
✅ BUY SIGNAL: CLYM shows strong fundamentals and good volume confirmation. Solid entry point despite fair pricing.
✅ BUY SIGNAL: CLYM shows strong fundamentals and good volume confirmation. Solid entry point despite fair pricing.
In-depth Analysis How we analyze
Valuation Analysis: CLYM is currently trading at $6.85, which is considered fair relative to its 30-day fair value range of $6.59 to $7.35.
Technical Outlook: Technically, CLYM is in a strong uptrend. Immediate support is located at $5.87, while resistance sits at $7.46. The stock is showing strong short-term momentum, up 4.7% recently.
Market Sentiment: The stock shows a mixed technical setup (55/100), with neutral trendline and momentum signals. Wall Street analysts see significant upside, with an average price target of $15.36 (+124.3%). Combining these factors, the current setup offers a favorable risk/reward ratio for buyers.
Technical Outlook: Technically, CLYM is in a strong uptrend. Immediate support is located at $5.87, while resistance sits at $7.46. The stock is showing strong short-term momentum, up 4.7% recently.
Market Sentiment: The stock shows a mixed technical setup (55/100), with neutral trendline and momentum signals. Wall Street analysts see significant upside, with an average price target of $15.36 (+124.3%). Combining these factors, the current setup offers a favorable risk/reward ratio for buyers.
Quick Decision Summary
Current Position
FAIR
Fair Price Range
$6.59 -
$7.35
Company Quality Score
53/100
(HOLD)
Volume Confirmation
HIGH
Confidence Score
80.0%
All Signals
- NEUTRAL: Price in fair range
- NEUTRAL: Mixed technical signals (55/100)
- BULLISH: High volume confirmation
- BULLISH: Strong upward momentum (+4.7%)
- BULLISH: Trading 124.3% below Wall St target ($15.36)
Fair Price Analysis
30-Day Fair Range
$6.59 -
$7.35
Current vs Fair Value
FAIR
Support & Resistance Levels
Support Level
$5.87
Resistance Level
$7.46
Current Trend
Strong Uptrend
Technical data as of
Mar 31, 2026
Fundamental Context
Forward P/E (Next Year Est.)
-4.69
Wall Street Target
$15.36
(+124.3%)
Share & Embed Analysis
Last updated: April 01, 2026 1:35 AM ET
Data refreshes hourly during market hours. Next update: 2:35 AM
Data refreshes hourly during market hours. Next update: 2:35 AM
🔥 Top Stocks Breaking Out Now
| Ticker | Score | Recommendation | Change % |
|---|
Technical Signals Check
Is CLYM showing a specific setup today?
Insider Activity (6 Months)
3
Buys
0
Sells
+
Net
INSIDERS BUYING
Recent Transactions
Ra Capital Management, L…
BUY
7111 shares
2026-01-05
Ra Capital Management, L…
BUY
101462 shares
2025-12-12
Ra Capital Management, L…
BUY
213099 shares
2025-12-11
Top Rated Biotechnology Stocks
Top-rated stocks in Biotechnology by analyst ratings.
| Stock | Analyst Consensus | Analyst Target | Tradestie Score |
|---|---|---|---|
|
RARE
Ultragenyx |
STRONG BUY
20 analysts |
$54 | 65 BUY |
|
AXSM
Axsome Therapeutics Inc |
STRONG BUY
19 analysts |
$222 | 57 HOLD |
|
CYTK
Cytokinetics Inc |
STRONG BUY
21 analysts |
$92 | 59 HOLD |
|
RVMD
Revolution Medicines Inc |
STRONG BUY
12 analysts |
$134 | 60 HOLD |
|
EXEL
Exelixis Inc |
BUY
20 analysts |
$47 | 63 BUY |
